AI and technology can be applied virtually everywhere in what we do todayOrthopedic technology company Zimmer Biomet hoping ...
Indexes careened through jarring swings as worries built about the financial health of small and midsized banks, as well as the souring U.S.-China trade relationship. Bank stocks steadied themselves ...
This MoneyShow Chart of the Day shows the 2-year/30-year US Treasury spread. That’s the difference between the yield on the 2-year Treasury Note and the yield on the 30-year Treasury Bond. You can see ...
Fintel reports that on October 13, 2025, BTIG maintained coverage of Zimmer Biomet Holdings (NYSE:ZBH) with a Buy ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $114.0, with a high estimate of $130.00 and a low estimate of $96.00. Observing a 5.88% ...
Zimmer Biomet is set to post its third-quarter results next month, and analysts project a single-digit earnings rise.
Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn ...
About Zimmer Biomet Holdings Inc. Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, ...
Zimmer Biomet (NYSE: ZBH) announced yesterday that it launched two new solutions for complex foot and ankle trauma.
Zimmer Biomet Holdings Inc., a global medical technology leader, and Paragon 28, a wholly owned subsidiary, announced Oct. 8 ...
Zimmer Biomet Holdings Inc. announced Oct. 7 that it has completed the acquisition of Monogram Technologies Inc., an ...
The launches of the Gorilla ® Pilon Fusion Plating System and the Phantom ® TTC Trauma Nail mark a significant expansion of Zimmer Biomet's foot and ankle trauma portfolio.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results